Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect?

T Szabó1, L Gellér, B Merkely

  • 1Department of Cardiovascular Surgery, Semmelweis University of Medicine, Budapest, Hungary. tamas.szabo@excite.com

Life Sciences
|July 7, 2000
PubMed

Insights

Endothelin-1 (ET-1) causes ventricular arrhythmias before ischemia. Intracoronary ET-1 reduced coronary blood flow but did not induce ischemia, unlike left anterior descending artery occlusion.

Area of Science:

  • Cardiology
  • Physiology

Background:

  • Endothelin-1 (ET-1) is a potent vasoconstrictor with arrhythmogenic potential.
  • Investigating ET-1's role in arrhythmias is crucial for understanding cardiac events.

Purpose of the Study:

  • Compare the arrhythmogenic effects of left anterior descending (LAD) artery occlusion versus intracoronary ET-1 administration.
  • Elucidate the underlying pathomechanism of ET-1-induced ventricular arrhythmias.

Main Methods:

  • Three groups of dogs underwent LAD occlusion or ET-1 infusion.
  • Electrophysiological parameters (monophasic action potentials), coronary blood flow, and lactate levels were monitored.
  • Infrared imaging assessed epimyocardial temperature changes.

Main Results:

  • ET-1 infusion significantly reduced coronary blood flow and epimyocardial temperature.
  • ET-1 administration induced ventricular arrhythmias, including ventricular fibrillation, in a dose-dependent manner.
  • Ischemic changes (lactate elevation, altered action potentials) were observed only in the LAD occlusion group.

Conclusions:

  • ET-1 can trigger severe ventricular arrhythmias independently of significant myocardial ischemia.
  • Reduced coronary blood flow by ET-1 may contribute to arrhythmia maintenance.
  • ET-1's arrhythmogenic effects manifest earlier than ischemic signs.

Related Concept Videos